[TNGX] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
31-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 66.93%
YoY-
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue 5,431 6,411 5,716 9,142 -15.93%
PBT -30,716 -29,009 -21,869 -8,864 51.32%
Tax 47 51 177 0 -
NP -30,763 -29,060 -22,046 -8,864 51.40%
Tax Rate - - - - -
Total Cost 36,194 35,471 27,762 18,006 26.20%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin -566.43 -453.28 -385.69 -96.96 80.10%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.32 -0.33 -0.25 -0.53 -15.48%
EPS Diluted -0.32 -0.33 -0.25 -0.42 -8.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.